Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Borregaard Capital/Financing Update 2019

Oct 17, 2019

3562_rns_2019-10-17_cf2cadfc-9893-4a66-8a21-4be4ee682334.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

Borregaard has decided to invest NOK 207 million in the chloralkali plant at the Sarpsborg site in Norway. The investment includes a new electrolyser and rectifier, new facilities for the preparation of brine and tanks for intermediate storage of co-products for external sale. The project will be completed in 2021. The investment is mainly a replacement and modernisation of existing equipment. It will also give a certain increase in production through improved operational stability, reduced energy consumption and improved logistics for serving external customers.

Caustic soda is a strategic process chemical used mainly in the production of speciality cellulose and biobased vanillin. Borregaard’s own production represents about two thirds of the total need at the Sarpsborg site, and the rest is purchased from external suppliers. The chloralkali plant in Sarpsborg was converted to membrane technology in 1997.

Sarpsborg, 17 October 2019

Contact:

Jørn Syvertsen, Director Investor Relations, +47 958 36 335

This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.